Advertisement

Topics

Aerie Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

16:01 EST 8 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Conference Call and Webcast Today, November 8th, at 5:00 p.m. ET Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first...

Other Sources for this Article

Aerie Pharmaceuticals
Richard Rubino, 908-947-3540
rrubino@aeriepharma.com
or
Burns McClellan, Inc., on behalf of Aerie Pharmaceuticals
Investors
Ami Bavishi, 212-213-0006
abavishi@burnsmc.com
or
Media
Justin Jackson, 212-213-0006
jjackson@burnsmc.com

NEXT ARTICLE

More From BioPortfolio on "Aerie Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...